Jeil Pharmaceutical Co.,Ltd (KRX:271980)

KRX:271980 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	225,130	166,115	249,173	306,279	-	-
Market Cap Growth	10.52%	-33.33%	-18.64%	-	-	-
Enterprise Value	301,168	219,930	307,855	346,439	-	-
Last Close Price	15450.00	11400.00	17100.00	20937.61	33666.10	62145.11
PE Ratio	11.47	-	49.79	-	-	-
PS Ratio	0.36	0.24	0.34	0.42	-	-
PB Ratio	0.92	0.76	1.46	1.87	-	-
P/TBV Ratio	1.15	0.91	1.62	1.99	-	-
P/OCF Ratio	-	51.70	-	-	-	-
EV/Sales Ratio	0.48	0.31	0.42	0.48	-	-
EV/EBITDA Ratio	8.64	-	16.50	-	-	-
EV/EBIT Ratio	13.18	-	34.64	-	-	-
Debt / Equity Ratio	0.38	0.35	0.42	0.33	0.29	0.29
Debt / EBITDA Ratio	2.67	-	3.82	-	-	2.30
Debt / FCF Ratio	-	-	-	-	3.48	-
Asset Turnover	1.25	1.39	1.54	1.64	1.68	1.71
Inventory Turnover	3.84	4.92	5.19	5.61	5.15	5.53
Quick Ratio	0.82	0.79	0.66	0.71	0.78	0.75
Current Ratio	1.30	1.18	1.04	1.12	1.28	1.27
Return on Equity (ROE)	13.46%	-15.45%	3.11%	-9.06%	-8.82%	4.08%
Return on Assets (ROA)	2.87%	-2.29%	1.18%	-1.89%	-1.55%	1.92%
Return on Capital (ROIC)	4.79%	-4.32%	2.41%	-3.84%	-2.97%	3.67%
Return on Capital Employed (ROCE)	8.80%	-7.90%	4.90%	-6.80%	-5.10%	6.50%
Earnings Yield	8.72%	-18.04%	2.01%	-4.27%	-	-
FCF Yield	-5.65%	-0.64%	-4.45%	-8.57%	-	-
Dividend Yield	-	-	0.29%	0.24%	-	-
Payout Ratio	-	-	14.55%	-	-	14.79%
Buyback Yield / Dilution	-0.02%	-	0.02%	0.23%	0.04%	0.41%
Total Shareholder Return	-0.02%	-	0.31%	0.47%	0.04%	0.41%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.